-
Hot Watch List: Hewlett-Packard Company (NYSE:HPQ), Enanta Pharmaceuticals (NASDAQ:ENTA), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Oplink Communications (NASDAQ:OPLK), HomeAway (NASDAQ:AWAY)
Hewlett-Packard Company (NYSE:HPQ) EVP Martin Fink sold 4,964 shares of the company’s stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $37.20, for a total value of $184,660.80. Following the transaction, the executive vice president now directly owns 1,194 shares of the company’s stock, valued at approximately…
-
Traders Are Gambling on: Enanta Pharmaceuticals (NASDAQ:ENTA), Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB), L Brands (NYSE:LB), AutoNation Inc. (NYSE:AN), Ericsson (NASDAQ:ERIC)
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has announced that the U.S. Food and Drug Administration has approved AbbVie’s VIEKIRA PAK(TM) for the Treatment of Chronic Genotype 1 Hepatitis C Virus. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) in last trading activity moved up 10.08% to close at $51.32. Company weekly performance is 19.04% while its quarterly performance stands at 32.99%.…
-
Mix Sector Stocks News: Tesla Motors Inc (NASDAQ:TSLA), Diplomat Pharmacy (NYSE:DPLO), United-Guardian Inc. (NASDAQ:UG), Enanta Pharmaceuticals (NASDAQ:ENTA), THL Credit (NASDAQ:TCRD)
Tesla Motors Inc (NASDAQ:TSLA) said Friday in a corporate blog post that it will install its first battery swap facility in California and invite some owners of the Model S electric sedan to participate at a “cost slightly less than a full tank of gasoline for a premium sedan.” Tesla Motors Inc (NASDAQ:TSLA) in last…
-
Big Moves in Focus: Enanta Pharmaceuticals (NASDAQ:ENTA), Boston Scientific (NYSE:BSX), Argo Group International (NASDAQ:AGII), International Business Machines (NYSE:IBM), ID Systems (NASDAQ:IDSY)
Enanta Pharmaceuticals (NASDAQ:ENTA) CEO Jay R. Luly sold 15,000 shares of the stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $45.39, for a total transaction of $680,850.00. Following the transaction, the chief executive officer now directly owns 514,338 shares in the company, valued at approximately $23,345,802.Enanta…
-
Top Morning News: Fifth Third Bancorp (NASDAQ:FITB), KeyCorp. (NYSE:KEY), Community Health Systems (NYSE:CYH), Stock Building Supply Holdings (NASDAQ:STCK), Enanta Pharmaceuticals (NASDAQ:ENTA)
Fifth Third Bancorp (NASDAQ:FITB) will present at the Goldman Sachs U.S. Financial Services Conference in New York City on Tuesday, December 9 at approximately 2:40 PM ET.Fifth Third Bancorp (NASDAQ:FITB) in last trading activity moved up 2.33% to close at $20.63. Company weekly performance is 2.53% while its quarterly performance stands at 2.03%. Fifth Third…
-
Investors Watch List: Enanta Pharmaceuticals (NASDAQ:ENTA), Weibo Corporation (NASDAQ:WB), Stewart Information Services Corporation (NYSE:STC), China Telecom Corp (NYSE:CHA), HFF (NYSE:HF)
Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) Monday reported fourth-quarter net loss of $5 million or $0.27 per share compared with $4.4 million or $0.25 per share last year. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) in last trading activity moved up 5.82% to close at $47.99. Company weekly performance is 9.32% while its quarterly performance stands at 9.49%. Enanta Pharmaceuticals,…
-
Top News: Texas Instruments Inc. (NASDAQ:TXN), Enanta Pharmaceuticals (NASDAQ:ENTA), 8×8 Inc. (NASDAQ:EGHT), Teleflex Incorporated (NYSE:TFX), Viad Corp (NYSE:VVI)
As of 3Q14, Texas Instruments Inc. (NASDAQ:TXN) generated an operating cash flow of $2.62 billion. It holds cash and short-term investments worth $3.19 billion and carries a total debt of $4.64 billion. The company has decent cash reserves. Until 2011, the company had no debt on its books. But in order to pay $6.5 billion…
-
Morning Watch List: Enanta Pharmaceuticals (NASDAQ:ENTA), Halliburton Company (NYSE:HAL), Boston Scientific Corporation (NYSE:BSX), Emerald Oil (NYSEMKT:EOX), Colony Financial (NYSE:CLNY)
The results of the studies conducted by Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) on chronic hepatitis C virus (HCV) patients with human immunodeficiency virus type 1 (HIV-1) co-infection (TURQUOISE-I) and liver transplant recipients (CORAL-I) have been presented at The Liver Meeting 2014. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) in last trading activity fell -0.21% to close at $43.22. Company…
-
Small Cap Losers: Himax Technologies(NASDAQ:HIMX), Inovio Pharmaceuticals(NASDAQ:INO), ImmunoGen(NASDAQ:IMGN), Omeros Corporation (NASDAQ:OMER), Enanta Pharmaceuticals(NASDAQ:ENTA)
Himax Technologies, Inc. (NASDAQ:HIMX) a leading supplier and fabless manufacturer of display drivers and other semiconductor products, announced that Google Inc. has decided not to exercise its previously issued purchase option to make an additional investment into Himax’s subsidiary, Himax Display Inc. (“HDI”). Himax has been authorized by Google to make the following statement: “Google…